Frank A. Post
0000-0002-2844-1612
Publication & Citation Trends
Publications
0 total
P-377. Efficacy and Safety by Age After Switch to Doravirine/Islatravir (100 mg/0.25 mg) Once Daily: Week 48 Results from Two Phase 3 Randomized, Active-Controlled Studies in Adults Living with HIV-1
Cited by 0
Semantic Scholar
Virological outcomes with Bictegravir/Emtricitabine/Tenofovir alafenamide (B/F/TAF) in people previously treated with darunavir-based antiretroviral therapy.
Cited by 0
Semantic Scholar
Screening for Trypanosoma cruzi infection (Chagas disease) in the Latin American population living with HIV in London.
Cited by 0
Semantic Scholar
Safety and biologic activity of a bispecific T cell receptor targeting HIV Gag in males living with HIV: a first-in-human trial
Cited by 0
Semantic Scholar
Durable efficacy of dolutegravir/rilpivirine switch in subjects with HIV RNA <50 copies/mL and history of K103N mutation.
Cited by 0
Semantic Scholar
Post-acute sequelae of COVID-19 in people of Black ethnicities living with HIV in the United Kingdom
Cited by 0
Semantic Scholar
Changes in multimorbidity burden and their impact on patient and healthcare outcomes in people with HIV over a 3–5-year period
Cited by 1
Semantic Scholar
Research Topics
HIV/AIDS drug development and treatment
(131)
HIV-related health complications and treatments
(127)
HIV/AIDS Research and Interventions
(121)
HIV Research and Treatment
(77)
Pneumocystis jirovecii pneumonia detection and treatment
(55)
Affiliations
Brighton and Sussex Medical School
Goethe University Frankfurt
National Health Service
St Thomas' Hospital
Roslin Institute